-transparent.png){kind=logo}
Leukocytes labeled with technetium-99m hexamethylpropyleneamine oxime (HMPAO) were used in 100 patients: 32 with suspected inflammatory bowel disease, 17 with fever of unknown origin, 21 with suspected abdominal sepsis, 20 with suspected bone sepsis, seven with bronchiectasis, and three with recent myocardial infarction. The distribution of activity in patients subsequently shown not to have inflammatory bowel disease was similar to that previously described for indium-111-labeled leukocytes. However, in this study, activity was also seen in the kidneys and bladder and occasionally the gallbladder on both early (1-3 hours) and late (24 hours) views, and in the colon in late views. Migration of Tc-99m-labeled granulocytes was seen in inflammatory disease as early as 30 minutes after injection, while normal bowel activity was not seen before 4 hours. The sensitivity of Tc99m-labeled leukocytes in the detection of inflammation was 100%, the specificity was 95%.
M E Roddie, and
A M Peters, and
H J Danpure, and
S Osman, and
B L Henderson, and
J P Lavender, and
M J Carroll, and
R D Neirinckx, and
J D Kelly
July 1991,
Annals of nuclear medicine,
M E Roddie, and
A M Peters, and
H J Danpure, and
S Osman, and
B L Henderson, and
J P Lavender, and
M J Carroll, and
R D Neirinckx, and
J D Kelly
July 1993,
Clinical nuclear medicine,
M E Roddie, and
A M Peters, and
H J Danpure, and
S Osman, and
B L Henderson, and
J P Lavender, and
M J Carroll, and
R D Neirinckx, and
J D Kelly
January 1997,
The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons,
M E Roddie, and
A M Peters, and
H J Danpure, and
S Osman, and
B L Henderson, and
J P Lavender, and
M J Carroll, and
R D Neirinckx, and
J D Kelly
March 1988,
Nuklearmedizin. Nuclear medicine,
M E Roddie, and
A M Peters, and
H J Danpure, and
S Osman, and
B L Henderson, and
J P Lavender, and
M J Carroll, and
R D Neirinckx, and
J D Kelly
December 1992,
Clinical nuclear medicine,
M E Roddie, and
A M Peters, and
H J Danpure, and
S Osman, and
B L Henderson, and
J P Lavender, and
M J Carroll, and
R D Neirinckx, and
J D Kelly
August 2009,
Clinical nuclear medicine,
M E Roddie, and
A M Peters, and
H J Danpure, and
S Osman, and
B L Henderson, and
J P Lavender, and
M J Carroll, and
R D Neirinckx, and
J D Kelly
December 1990,
Clinical nuclear medicine,
M E Roddie, and
A M Peters, and
H J Danpure, and
S Osman, and
B L Henderson, and
J P Lavender, and
M J Carroll, and
R D Neirinckx, and
J D Kelly
November 2002,
Clinical nuclear medicine,
M E Roddie, and
A M Peters, and
H J Danpure, and
S Osman, and
B L Henderson, and
J P Lavender, and
M J Carroll, and
R D Neirinckx, and
J D Kelly
November 1977,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
M E Roddie, and
A M Peters, and
H J Danpure, and
S Osman, and
B L Henderson, and
J P Lavender, and
M J Carroll, and
R D Neirinckx, and
J D Kelly
September 1990,
Clinical nuclear medicine,
